Thy-1 is the most abundant glycoprotein in rat neurons and appears during normal development at the time of neuronal differentiation and synaptogenesis. Homologous Thy-1 molecules exist in species from invertebrates to man. As previously shown by the principal investigator, antibodies against Thy-1 enhance the regeneration of neurites by rat retinal ganglion cells in culture (Leifer et al., Science 1984; 224:303- 306). Additional knowledge about Thy-1 thus should contribute to a better understanding of congenital anomalies in which abnormal central nervous system morphogenesis is accompanied by mental retardation, intractable epilepsy, and motor system disorders. Moreover, further studies of the role of Thy-1 in regeneration may make it possible to treat injuries to the brain, such as those induced by perinatal hypoxia and ischemia, which are also prominent causes of mental retardation, epilepsy, and motor disorders, especially spasticity and choreothetosis. Preliminary experiments by Drs. Lipton and Neve have tentatively identified a Thy-1 receptor. We propose in this grant first to identify definitively and characterize a Thy-1 receptor by using molecular biological techniques. Subsequent experiments will study its expression during development, examine its effects on neurons growing in culture, and look for homologous molecules in different species.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Physician Scientist Award (K11)
Project #
7K11HD000888-06
Application #
3087054
Study Section
Mental Retardation Research Committee (HDMR)
Project Start
1989-07-01
Project End
1994-06-30
Budget Start
1993-09-01
Budget End
1994-06-30
Support Year
6
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Speliotes, E K; Kowall, N W; Shanti, B F et al. (1996) Myocyte-specific enhancer binding factor 2C expression in gerbil brain following global cerebral ischemia. Neuroscience 70:67-77
Krainc, D; Haas, M; Ward, D C et al. (1995) Assignment of human myocyte-specific enhancer binding factor 2C (hMEF2C) to human chromosome 5q14 and evidence that MEF2C is evolutionarily conserved. Genomics 29:809-11
Leifer, D; Golden, J; Kowall, N W (1994) Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience 63:1067-79
Leifer, D; Krainc, D; Yu, Y T et al. (1993) MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc Natl Acad Sci U S A 90:1546-50
Leifer, D; Kowall, N W (1993) Immunohistochemical patterns of selective cellular vulnerability in human cerebral ischemia. J Neurol Sci 119:217-28
Leifer, D; Kowall, N W (1992) Thy-1 in hippocampus: normal anatomy and neuritic growth in Alzheimer's disease. J Neuropathol Exp Neurol 51:133-41
Lipton, S A; Leifer, D; Barnstable, C J (1992) Selectivity of Thy-1 monoclonal antibodies in enhancing neurite outgrowth. Neurosci Lett 137:75-7
Schmahmann, J D; Leifer, D (1992) Parietal pseudothalamic pain syndrome. Clinical features and anatomic correlates. Arch Neurol 49:1032-7
Leifer, D; Dreyer, E B; Lipton, S A (1991) Immunofluorescent characterization of retinal ganglion cell neurites cultured on substrates coated with antibodies against Thy-1. Exp Neurol 113:386-90
Leifer, D; Cole, D G; Kowall, N W (1991) Neuropathologic asymmetries in the brain of a patient with a unilateral status epilepticus. J Neurol Sci 103:127-35